Phase 2 Study of Gemcitabine or Gemcitabine + Enzastaurin in Participants With Advanced or Metastatic Pancreatic Cancer
Status:
Completed
Trial end date:
2008-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to determine the effects and toxicity of gemcitabine
alone or gemcitabine plus enzastaurin in participants with pancreatic cancer.